When Grammy-nominated singer-songwriter Aloe Blacc got COVID despite being vaccinated and boosted, he tried to fund research for a better solution. What he quickly found out? You can’t just write a check in biotech. Regulators require a commercialization plan, and philanthropy doesn’t move science through clinical trials or get you a license on university IP. Now, he’s bootstrapping a cancer drug platform targeting pancreatic cancer, a disease that […]
Aloe Blacc’s fame means nothing in biotech (and that’s the point)
Originally reported by TechCrunch
Related Articles
Nuro receives driverless testing permit ahead of Uber robotaxi service launch
Nuro has been granted a permit to begin driverless testing of Lucid Gravity SUVs equipped with its autonomous tech on Ca...
SAP bets $1.16B on 18-month-old German AI lab and says yes to NemoClaw
By OpenAI COO’s own admission last February, ‘we have not yet really seen AI penetrate enterprise business processes.’ B...
‘I Actually Thought He Was Going to Hit Me,’ OpenAI’s Greg Brockman Says of Elon Musk
CommentLoaderSave StorySave this storyCommentLoaderSave StorySave this storyIn August 2017, Greg Brockman and Ilya Sutsk...
Bumble’s paying users are slipping as it bets on an overhaul later this year
As Bumble gets ready for a big overhaul meant to win back Gen Z users (who are pretty over dating apps right now), its l...